FDA approves Zynyz for advanced anal cancer, marking a breakthrough for the 10,000 diagnosed annually—including actress ...

Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer and the fourth leading cause of cancer-related death, has a 5-year survival rate of less than 10%.1 The impact of pancreatic ...

Dedicated to the future of cancer treatment, this topic covers emerging targeted and immunotherapeutic approaches in solid tumors and hematologic ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

Despite groundbreaking advances in pediatric cancer research, many promising therapies never reach the children who need them most. Catherine Bollard, MD, is senior vice president and chief research ...

Researchers from USask have identified a potential target for eliminating breast cancer cells. The team was led by Dr. Franco ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

The family of a young dad living with terminal brain cancer has welcomed groundbreaking research that could revolutionise ...

King Charles has sent a personal message to fellow cancer patients, speaking of the "daunting and at times frightening experience" for cancer sufferers and their loved ones. In a heartfelt message ...

King Charles shared a touching update in his ongoing fight against cancer and what he’s learned from his diagnosis. The king wrote a message that was printed in a booklet and handed out during ...

BEREA, Ohio (WJW) — From cancer to multiple sclerosis, and even extreme cases of obsessive-compulsive disorder, a growing number of patients say a return to nature is changing — and saving ...